 |
| |
 | | Drug Therapy | |
- Recognize that topical antibacterial antibiotics are ineffective in acute viral conjunctivitis.
- Consider conferring with an ophthalmologist about judicious use of topical steroids for some of the complications of viral conjunctivitis.
- Consider topical antibiotics only if there is clear evidence of bacterial superinfection.
- Consider antihistamines, nonsteroidal agents, and mast-cell stabilizers when allergic forms of conjunctivitis are suspected.
| | Drug Treatment for Conjunctivitis (table)
|
| 
Recognize that topical antibacterial antibiotics are ineffective in acute viral conjunctivitis.  |
- Do not prescribe prophylactic use of antibiotics to prevent secondary bacterial infections in patients with known viral conjunctivitis.
| Background | Back to top
| 
Consider conferring with an ophthalmologist about judicious use of topical steroids for some of the complications of viral conjunctivitis.  |
- Avoid topical steroids for treating acute diseases
- Consider the following indications for topical steroids for the associated inflammatory phases of adenoviral conjunctivitis:
- Corneal infiltrates associated with epidemic keratoconjunctivitis that can cause severe photophobia and blurred vision
- Pseudomembranes, which are dense exudates firmly adherent to the palpebral conjunctiva
- Be aware that topical steroids are associated with serious and blinding ocular complications, including cataracts and glaucoma, and their use should be restricted to an ophthalmologist.
- See table Drug Treatment for Conjunctivitis.
| Background | Back to top
| 
Consider topical antibiotics only if there is clear evidence of bacterial superinfection.  |
- Use topical broad spectrum antibiotics, such as fluoroquinolones, when:
- Purulent discharge signifies bacterial infection is present
- Conjunctival culture results of purulent discharge are positive
- Patients have concurrent contact lens use
- See table Drug Treatment for Conjunctivitis.
| Background | Back to top
| 
Consider antihistamines, nonsteroidal agents, and mast-cell stabilizers when allergic forms of conjunctivitis are suspected.  |
- Consider antihistamines and vasoconstrictors, such as naphazoline and naphazoline pheniramine, in mild allergic conjunctivitis.
- Consider nonsteroidal drugs such as diclofenac and ketorolac in more severe cases of conjunctivitis.
- Note that mast-cell stabilizers such as cromolyn sodium, lodoxamide, and olopatadine can also be used in allergic forms of conjunctivitis.
- See table Drug Treatment for Conjunctivitis.
| Background | Back to top
|  | | FAQs |
|
| Robert Sambursky, MD, editorial consultant, Chief Medical Officer for Rapid Pathogen Screening, Inc.;served as consultant for Rapid Pathogen Screening, Inc.;received an honoraria for Rapid Pathogen Screening, Inc.;serves as consultant for Rapid Pathogen Screening, Inc; owns stock options in Rapid Pathogen Screening, Inc.;served as board member or director for Rapid Pathogen Screening, Inc.;received grants and has grants pending from Rapid Pathogen Screening, Inc.;and has received patents and has patents pending for Rapid Pathogen Screening, Inc. Stephen Orlin, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|